Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sartorius Stedim Biotech
Aubagne, Provence-Alpes-Côte d'Azur, France
- Ownership
- Private
- Employees
- ~9900
- Development stage
- Other
01
Overview
Sartorius Stedim Biotech is a leading global provider of integrated solutions for developing and manufacturing biopharmaceuticals, including biologics, cell therapies, mRNA drugs, and vaccines. The company does not develop therapeutic products itself but provides essential products and platforms for drug manufacturers throughout all stages of commercial and clinical development, with no own clinical trial results.
- Modalities
- BiologicCell therapymRNA-based drugsMonoclonal antibodyVaccineProtein
- Industry
- Chemicals & Materials
02
Partnerships
BaxterPharmaciaTulip InterfacesNova BiomedicalSynpromics
Beyond the preview
Go deeper on Sartorius Stedim Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sartorius Stedim Biotech.